These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 752894)

  • 1. Blood group specific components and systems in multiple sclerosis. Preliminary report.
    Wender M; Przybylski Z; Chmielewska U
    Riv Patol Nerv Ment; 1978; 99(1):14-21. PubMed ID: 752894
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Multiple sclerosis susceptibility and histocompatibility determinants.
    Alter M; Harshe M; Yunis EJ
    Neurology; 1975 May; 25(5):489. PubMed ID: 1169709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Major histocompatibility system in multiple sclerosis].
    Oger J; Sabouraud O; Fauchet R; Genetet N; Menault F; Genetet B
    Rev Neurol (Paris); 1976 Feb; 132(2):89-97. PubMed ID: 973072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histocompatibility-linked immune-response determinants in multiple sclerosis.
    Jersild C; Dupont B; Fog T; Hansen GS; Nielsen LS; Thomsen M; Svejgaard A
    Transplant Proc; 1973 Dec; 5(4):1791-6. PubMed ID: 4130083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenetics of multiple sclerosis: relationship between histocompatibility antigens and susceptibility to the disease].
    Smeraldi E
    Boll Ist Sieroter Milan; 1972; 51(3):220-3. PubMed ID: 4653137
    [No Abstract]   [Full Text] [Related]  

  • 6. Histocompatibility antigens and their relevance to multiple sclerosis.
    Batchelor JR
    Br Med Bull; 1977 Jan; 33(1):72-7. PubMed ID: 318892
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Histocompatibility determinants in multiple sclerosis.
    Degos L; Dausset J
    Lancet; 1974 Feb; 1(7852):307-8. PubMed ID: 4130484
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA studies on multiple sclerosis in Japan.
    Saito S; Naito S; Kawanami S; Kurowa Y
    Neurology; 1976 Jun; 26(6 PT 2):49. PubMed ID: 944894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Distribution of isoantigens (HLA) in multiple sclerosis].
    Mazzilli MC; Baricordi O; Carolei A; Lulli P; Trabace S; Costanzi S
    Boll Soc Ital Biol Sper; 1976 May; 52(10):704-10. PubMed ID: 949382
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: HL-A-antigen segregation analysis in multiple sclerosis.
    Bertrams J; Kuwert E
    Lancet; 1974 Jul; 2(7871):43-4. PubMed ID: 4134426
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple sclerosis immunogenetics. A possible correlation with human leukocyte HL-A antigens.
    Cazzullo CL; Smeraldi E
    Arzneimittelforschung; 1975 Nov; 25(11):1826-8. PubMed ID: 1106444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Gc" blood groups in multiple sclerosis].
    Paltrinieri E; Giovannucci M
    Arch Sci Med (Torino); 1968 Dec; 125(12):782-5. PubMed ID: 5736195
    [No Abstract]   [Full Text] [Related]  

  • 14. Histocompatibility studies and multiple sclerosis.
    McFarlin DE; McFarland HF
    Arch Neurol; 1976 Jun; 33(6):395-8. PubMed ID: 1084740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood groups in multiple sclerosis].
    Wender M; Przybylski Z; Stawarz M; Chmielewska U
    Pol Tyg Lek; 1980 Oct; 35(43):1637-9. PubMed ID: 7255249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetic control of the complement level by the principal histocompatibility complex].
    Hauptmann G; Tongio MM; Mayer S
    Nouv Presse Med; 1976 Sep; 5(30):1914-5. PubMed ID: 980705
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of association between HLA-Dw2 and multiple sclerosis in Israeli Jewish patients.
    Brautbar N; Lahana E; Alter M; Jorgensen F; Lamm L
    N Engl J Med; 1977 Jun; 296(26):1537-8. PubMed ID: 865542
    [No Abstract]   [Full Text] [Related]  

  • 18. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.
    Jersild C; Fog T; Hansen GS; Thomsen M; Svejgaard A; Dupont B
    Lancet; 1973 Dec; 2(7840):1221-5. PubMed ID: 4128558
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland.
    Greve B; Simonenko R; Illes Z; Peterfalvi A; Hamdi N; Mycko MP; Selmaj KW; Rozsa C; Rajczy K; Bauer P; Berger K; Weissert R
    Mult Scler; 2008 Mar; 14(2):153-8. PubMed ID: 17942509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies in familial multiple sclerosis.
    Ebers GC; Paty DW
    Trans Am Neurol Assoc; 1980; 105():344-7. PubMed ID: 6960592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.